Director, Operations Finance at Cellares

Bridgewater, New Jersey, United States

Cellares Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Manufacturing, BiotechnologyIndustries

Requirements

  • Bachelor’s degree in finance, accounting, or a related field
  • 10+ years of relevant demonstrated financial and leadership experience
  • Extensive experience with SAP or other relevant ERP solutions
  • Experience with analysis tools and databases such as SQL, Power Query, Power BI, Snowflake, and Tableau
  • Highly organized with a meticulous attention to detail and the willingness to be in a hands-on position
  • Deep understanding of industry financials
  • Proven track record of financial leadership in a fast-paced, dynamic environment
  • Strong analytical and problem-solving skills, with the ability to synthesize complex information into clear recommendations
  • Excellent communication and interpersonal skills, with the ability to work effectively with both internal teams and external partners
  • Extensive FP&A, accounting, manufacturing, supply chain, and business partnering experience with a track record of success
  • Intellectually curious, detail-oriented, and able to collaboratively drive solutions to complex problems
  • Ability to drive the performance of the organization through financial insights and foresight

Responsibilities

  • Work collaboratively with the Chief Operating Officer and Operations leadership to provide financial support and business partnering for the Operations organization
  • Manage all aspects of FP&A for Operations, such as forecasting, monthly budget vs. actual, and analysis
  • Provide insights into key opportunities and profitability for potential projects to ensure each is financially viable and aligns with the company’s strategic goals
  • Develop and maintain the manning plan for our manufacturing sites to ensure gross margin targets are achieved and drive cost improvement projects to improve gross margins over time
  • Support the creation of business and financial presentations (e.g., board decks, Quarterly Business Reports, etc.) for Operations-related activities
  • Establish and lead Operations Finance teams at our manufacturing site in Bridgewater, Europe, and Japan
  • As part of the Company’s annual audit process, prepare supporting and supplemental information as requested by the Company’s auditors, as it relates to Operations
  • Support the Operations organization worldwide, including manufacturing sites in Bridgewater, NJ, Europe, and Japan
  • Responsible for product costing and driving operational efficiencies to improve gross margin
  • Lead the cost forecast process for assets under development and new products in the commercial pipeline

Skills

FP&A
Accounting
Manufacturing Finance
Supply Chain Finance
Product Costing
Forecasting
Budgeting
Variance Analysis
Gross Margin Optimization
Business Partnering
Cost Improvement

Cellares

Develops and manufactures cell therapies efficiently

About Cellares

Cellares develops and manufactures cell therapies in the biotechnology sector, operating as an Integrated Development and Manufacturing Organization (IDMO). Its proprietary "Smart Factory" technology features an automated single-use cartridge system, which increases productivity and reduces costs and process failures compared to traditional methods. The company serves a range of clients, including pharmaceutical companies, and aims to provide efficient and cost-effective manufacturing services for cell therapies. Cellares stands out by combining development and manufacturing processes under one roof, making it a competitive option in the industry.

South San Francisco, CaliforniaHeadquarters
2019Year Founded
$345.3MTotal Funding
SERIES_CCompany Stage
Industrial & Manufacturing, BiotechnologyIndustries
201-500Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Stock Options

Risks

Emerging biotech startups threaten Cellares' market share with similar solutions.
Potential regulatory delays could impact scaling of new automated systems like Cell Q.
Supply chain vulnerabilities may disrupt production timelines for Cell Shuttle and Cell Q.

Differentiation

Cellares' Cell Shuttle offers 10x scalability over manual cell therapy manufacturing.
The Smart Factory technology integrates development and manufacturing, unlike traditional CDMOs.
Cell Q automates QC processes, addressing bottlenecks in cell therapy quality control.

Upsides

Partnership with Sony enhances precision in cell therapy manufacturing processes.
Strategic partnership with Bristol Myers Squibb provides financial boost and validation.
Ossama Eissa's appointment as COO accelerates global expansion and operational capabilities.

Land your dream remote job 3x faster with AI